Sept 11 (Reuters) - Zentiva as:
* ZENTIVA, A LEADING EUROPEAN GENERICS PHARMACEUTICAL
COMPANY,
ANNOUNCES SALE FROM ADVENT TO GTCR
* ZENTIVA: DEAL CLOSING IS EXPECTED TO TAKE PLACE IN EARLY
2026
Source text:
Further company coverage: